Darwinian medicine: A case for cancer

Nature Reviews Cancer

Volumn 7, Issue 3, 2007, Pages 213-221

  Greaves, Mel ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER RISK; CARCINOGENESIS; GENE MUTATION; HUMAN; MOLECULAR CLONING; MOLECULAR DYNAMICS; MOLECULAR EVOLUTION; NONHUMAN; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; REVIEW;

ADAPTATION, BIOLOGICAL; ANIMALS; EVOLUTION; HUMANS; NEOPLASMS; SELECTION (GENETICS); SPECIES SPECIFICITY;

EID: 33847237571     PISSN: 1474175X     EISSN: None     Source Type: Journal    
DOI: 10.1038/nrc2071     Document Type: Review

References (152)

1. Komarova, N. L. & Wodarz, D. Evolutionary dynamics of mutator phenotypes in cancer: implications for chemotherapy. Cancer Res. 63, 6635-6642 (2003).
2. Evan, G. I. Can't kick that oncogene habit. Cancer Cell 10, 345-347 (2006).
3. Murray, C. J. L. & Lopez, A. D. (eds) The global burden of disease: a comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020 (Harvard University Press, Cambridge, Massachusetts, 1996).
4. Jones, S. B. Cancer in the developing world: a call to action. Brit. Med. J. 319, 505-508 (1999).
5. Plesnicar, S. (ed.). Cancer in the Emerging World (W B Saunders, Philadelphia, 2001).
6. Shimkin, M. B. Contrary to nature - cancer (US Department of Health, Education and Welfare, Public Health Service, National Institutes of Health, 1977).
7. Brothwell, D. R. & Sandison, A. T. Diseases in antiquity (Charles Thomas Publishers, Illinois, 1967).
8. Greaves, M. Cancer. The Evolutionary Legacy (Oxford University Press, Oxford, 2000).
9. Welch, H. G. & Black, W. C. Using autopsy series to estimate the disease 'reservoir' for ductal carcinoma in situ of the breast: how much more breast cancer can we find? Ann. Int. Med. 127, 1023-1028 (1997).
10. Kassouf, W., Aprikian, A. G., Laplante, M. & Tanguay, S. Natural history of renal masses followed expectantly. J. Urol. 171, 111-113 (2004).
11. Franceschi, S. & La Vecchia, C. in Trends in cancer incidence and mortality (eds Doll, R., Fraumeni, J. F. J. & Muir, C. S.) 393-414 (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, 1994).
12. Mutter, G. L. et al. Molecular identification of latent precancers in histologically normal endometrium. Cancer Res. 61, 4311-4314 (2001).
13. Larson, P. S., de las Morenas, A., Cupples, L. A., Huang, K. & Rosenberg, C. L. Genetically abnormal clones in histologically normal breast tissue. Am. J. Pathol. 152, 1591-1598 (1998).
14. Westra, W. H. et al. K-ras oncogene activation in atypical alveolar hyperplasias of the human lung. Cancer Res. 56, 2224-2228 (1996).
15. Jin, C. et al. Clonal chromosome aberrations accumulate with age in upper aerodigestive tract mucosa. Mutat. Res. 374, 63-72 (1997).
16. Mori, H. et al. Chromosome translocations and covert leukemic clones are generated during normal fetal development. Proc. Natl Acad. Sci. USA 99, 8242-8247 (2002).
17. Schlumberger, H. G. & Lucke, B. Tumors of fishes, amphibians and reptiles. Cancer Res. 8, 657-754 (1948).
18. Rothschild, B. M., Tanke, D., Hershkovitz, I. & Schultz, M. Mesozoic neoplasia: origins of haemangioma in the Jurassic age. Lancet 351, 1862 (1998).
19. Rothschild, B. M., Witzke, B. J. & Hershkovitz, I. Metastatic cancer in the Jurassic. Lancet 354, 398 (1999).
20. Becker, F. F. (ed.) Cancer (Plenum Press, New York, 1975).
21. National Cancer Institute. Neoplasms and related disorders of invertebrate and lower vertebrate animals. Monograph 31 (1969).
22. Clevers, H. Stem cells, asymmetric division and cancer. Nature Genet. 37, 1027-1028 (2005).
23. Pinkston, J. M., Garrigan, D., Hansen, M. & Kenyon, C. Mutations that increase the life span of C. elegans inhibit tumor growth. Science 313, 971-975 (2006).
24. Aguirre, A. A., Brojer, C. & Morner, T. Descriptive epidemiology of roe deer mortality in Sweden. J. Wildl. Dis. 35, 753-762 (1999).
25. Lipscomb, T. P. et al. Common metastatic carcinoma of California sea lions (Zalophus californianus): evidence of genital origin and association with novel gammaherpesvirus. Vet. Pathol. 37, 609-617 (2000).
26. Priester, W. A. & McKay, F. W. The occurrence of tumors in domestic animals. Natl Cancer Inst. Monogr. 54, 1-210 (1980).
27. MacVean, D. W., Monlux, A. W., Anderson, P. S. J., Silberg, S. L. & Roszel, J. F. Frequency of canine and feline tumors in a defined population. Vet. Pathol. 15, 700-715 (1978).
28. Fowler, M. E. in Veterinary cancer medicine (eds. Theilen, G. H. & Madewell, B. R.) 649-662 (Lea & Febiger, Philadelphia, 1987).
29. Priester, W. A. & Mantel, N. Occurrence of tumors in domestic animals. Data from 12 United States and Canadian colleges of veterinary medicine. J. Natl Cancer Inst. 47, 1333-1344 (1971).
30. Montali, R. J. & Migaki, G. (eds) Pathology of zoo animals (Smithsonian Institution Press, Washington DC, 1980).
31. Harrenstien, L. A., Munson, L., Seal, U. S. & American Zoo and Aquarium Association Mammary Cancer Study Group. Mammary cancer in captive wide felids and risk factors for its development: a retrospective study of the clinical behaviour of 31 cases. J. Zoo Wildlife Med. 27, 468-476 (1996).
32. Cotchin, E. A general survey of tumours in the horse. Equine Vet. J. 9, 16-21 (1977).
33. Greisemer, R. A. in Handbook of laboratory animal science Vol. 3 (eds Hau, J. & van Hoosier, G.) 309-323 (CRC Press, Cleveland, 1976).
34. Leroi, A. M., Koufopanou, V. & Burt, A. Cancer selection. Nature Rev. Cancer 3, 226-231 (2003).
35. Olson, M. V. & Varki, A. Sequencing the chimpanzee genome: insights into human evolution and disease. Nature Rev. Genet. 4, 20-28 (2003).
36. Lair, S., Barker, I. K., Mehren, K. G. & Williams, E. S. Epidemiology of neoplasia in captive black-footed ferrets (Mustela nigripes), 1986-1996. J. Zoo Wildl. Med. 33, 204-213 (2002).
37. Martineau, D. et al. Cancer in wildlife, a case study: beluga from the St. Lawrence estuary, Québec, Canada. Environ. Health Perspect. 110, 285-291 (2002).
38. Williams, G. C. & Nesse, R. M. The dawn of Darwinian medicine. Q. Rev. Biol. 66, 1-22 (1991).
39. Nesse, R. M., Stearns, S. C. & Omenn, G. S. Medicine needs evolution. Science 311, 1071 (2006).
40. Nesse, R. M. & Williams, G. Evolution and healing. The new science of Darwinian medicine (Weidenfeld & Nicolson, 1995).
41. Stearns, S. C. (ed.) Evolution in health and disease (Oxford University Press, Oxford, 1999).
42. Stearns, S. C. & Ebert, D. Evolution in health and disease. Q. Rev. Biol. 76, 417-432 (2001).
43. Ewald, P. W. Evolution of infectious disease (Oxford University Press, Oxford, 1994).
44. Gluckman, P. & Hanson, M. Mismatch. Why our world no longer fits our bodies (Oxford University Press, Oxford, 2006).
45. Nowell, P. C. The clonal evolution of tumor cell populations. Science 194, 23-28 (1976).
46. Wodarz, D. Somatic evolution of cancer cells. Semin. Cancer Biol. 15, 436-450 (2005).
47. Merlo, L. M. F., Pepper, J. W., Reid, B. J. & Maley, C. C. Cancer as an evolutionary process. Nature Rev. Cancer 6, 924-935 (2006).
48. Mayr, E. One long argument. Charles Darwin and the genesis of modern evolutionary thought (Harward University Press, Boston, 1991).
49. Williams, G. C. Adaptation and natural selection (Princeton University Press, Princeton, New Jersey, 1966).
50. Dawkins, R. The blind watchmaker (Langman Sci Tech, Harlow, UK, 1986).
51. Ridley, M. Evolution (Blackwell Science, Cambridge, MA, 1996).
52. Futreal, P. A. et al. A census of human cancer genes. Nature Rev. Cancer 4, 177-183 (2004).
53. Sjöblom, T. et al. The consensus coding sequences of human breast and colorectal cancers. Science 314, 268-274 (2006).
54. Sniegowski, P. Evolution: setting the mutation rate. Curr. Biol. 7, R487-R488 (1997).
55. Weinberg, R. A. The biology of cancer (Garland Science, New York, 2007).
56. Bridges, B. A. Spontaneous mutation: some conceptual difficulties. Mutat. Res. 304, 13-17 (1994).
57. Khanna, K. K. & Jackson, S. P. DNA double-strand breaks: signaling, repair and the cancer connection. Nature Genet. 27, 247-254 (2001).
58. Vilenchik, M. M. & Knudson, A. G. Endogenous DNA double-strand breaks: production, fidelity of repair, and induction of cancer. Proc. Natl Acad. Sci. USA 100, 12871-12876 (2003).
59. Greaves, M. F. & Wiemels, J. Origins of chromosome translocations in childhood leukaemia. Nature Rev. Cancer 3, 639-649 (2003).
60. Lieber, M. R. Pathological and physiological double-strand breaks. Roles in cancer, aging, and the immune system. Am. J. Pathol. 153, 1323-1332 (1998).
61. Rabbitts, T. H. Chromosomal translocations in human cancer. Nature 372, 143-149 (1994).
62. Shaffer, A. L., Rosenwald, A. & Staudt, L. M. Lymphoid malignancies: the dark side of B-cell differentiation. Nature Rev. Immunol 2, 920-933 (2002).
63. Pasqualucci, L. et al. BCL-6 mutations in normal germinal center B cells: evidence of somatic hypermutation acting outside Ig loci. Proc. Natl Acad. Sci. USA 95, 11816-11821 (1998).
64. Cha, R. S., Thilly, W. G. & Zarbl, H. N-nitroso-N- methylurea-induced rat mammary tumors arise from cells with preexisting oncogenic Hras1 gene mutations. Proc. Natl Acad. Sci. USA 91, 3749-3753 (1994).
65. Jonason, A. S. et al. Frequent clones of p53-mutated keratinocytes in normal human skin. Proc. Natl Acad. Sci. USA 93, 14025-14029 (1996).
66. Yang, X., Lee, K., Said, J., Gong, X. & Zhang, K. Association of Ig/BCL6 translocations with germinal center B lymphocytes in human lymphoid tissues: implications for malignant transformation. Blood 108, 2006-2012 (2006).
67. Thilly, W. G. Have environmental mutagens caused oncomutations in people? Nature Genet. 34, 255-259 (2003).
68. Greaves, M. Infection, immune responses and the aetiology of childhood leukaemia. Nature Rev. Cancer 6, 193-203 (2006).
69. Papac, R. J. Spontaneous regression of cancer. Cancer Treat. Rev. 22, 395-423 (1996).
70. Holman, D. J. & Wood, J. W. in Reproductive ecology and human evolution (ed. Ellison, P. T.) 15-38 (Aldine, 2001).
71. Leroi, A. M. Mutants: on the form, varieties and errors of the human body (HarperCollins, London, 2004).
72. Crow, J. F. The odds of losing at genetic roulette. Nature 397, 293-294 (1999).
73. Eyre-Walker, A. & Keightley, P. D. High genomic deleterious mutation rates in hominids. Nature 397, 344-347 (1999).
74. Topczewska, J. M. et al. Embryonic and tumorigenic pathways converge via Nodal signaling: role in melanoma aggressiveness. Nature Med. 12, 925-932 (2006).
75. Thiery, J. P. Epithelial-mesenchymal transitions in tumour progression. Nature Rev. Cancer 2, 442-454 (2002).
76. Hancock, B. W., Newlands, E. S. & Berkowitz, R. S. (eds) Gestational trophoblastic disease (Chapman & Hall Medical Publishers, London, 1997).
77. Maris, J. M. & Denny, C. T. Focus on embryonal malignancies. Cancer Cell 2, 447-450 (2002).
78. Graham, J. Cancer selection: the new theory of evolution (Aculeus, Lexington, 1992).
79. Parkin, D. M. et al. (eds) International incidence of childhood cancer (IARC Scientific Publications, Lyon, 1988).
80. Cairns, J. Mutation selection and the natural history of cancer. Nature 255, 197-200 (1975).
81. Reya, T., Morrison, S. J., Clarke, M. F. & Weissman, I. L. Stem cells, cancer, and cancer stem cells. Nature 414, 105-111 (2001).
82. Pardal, R., Clarke, M. F. & Morrison, S. J. Applying the principles of stem-cell biology to cancer. Nature Rev. Cancer 3, 895-902 (2003).
83. Knudson, A. G. Stem cell regulation, tissue ontogeny, and oncogenic events. Semin. Cancer Biol. 3, 99-106 (1992).
84. Nunney, L. Lineage selection and the evolution of multistage carcinogenesis. Proc. R. Soc. Lond. B 266, 493-498 (1999).
85. Galis, F. & Metz, J. A. J. Anti-cancer selection as a source of developmental and evolutionary constraints. Bioessays 25, 1035-1039 (2003).
86. Kavanagh, K. D. Embedded molecular switches, anticancer selection, and effects on ontogenetic rates: a hypothesis of developmental constraint on morphogenesis and evolution. Evolution 57, 939-948 (2003).
87. Zhang, J. et al. PTEN maintains haematopoietic stem cells and acts in lineage choice and leukaemia prevention. Nature 441, 518-522 (2006).
88. Reya, T. & Clevers, H. Wnt signalling in stem cells and cancer. Nature 434, 843-850 (2005).
89. Meletis, K., Wirta, V., Hede, S.-M., Nistér, M. & Lundeberg, J. p53 suppresses the self-renewal of adult neural stem cells. Development 133, 363-369 (2006).
90. INK4a. Nature 443, 421-426 (2006).
91. Bartkova, J. et al. DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature 434, 864-870 (2005).
92. Gorgoulis, V. G. et al. Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions. Nature 434, 907-912 (2005).
93. Clevers, H. Stem cells, asymmetric division and cancer. Nature Genet. 37, 1027-1028 (2005).
94. Merok, J. R., Lansita, J. A., Tunstead, J. R. & Sherley, J. L. Cosegregation of chromosomes containing immortal DNA strands in cells that cycle with asymmetric stem cell kinetics. Cancer Res. 62, 6791-6795 (2002).
95. Damelin, M., Sun, Y. E., Brundula Sodja, V. & Bestor, T. H. Decatenation checkpoint deficiency in stem and progenitor cells. Cancer Cell 8, 479-484 (2005).
96. Cavalli-Sforza, L. L. Genes, people and language (Alan Lane Penguin Press, London, 2000).
97. Szabo, C. I. & King, M.-C. Population genetics of BRCA1 and BRCA2. Am. J. Hum. Genet. 60, 1013-1020 (1997).
98. Eaton, S. B. et al. Evolutionary health promotion. Prev. Med. 34, 109-118 (2002).
99. Loomis, W. F. Skin-pigment regulation of vitamin-D biosynthesis in man. Science 157, 501-506 (1967).
100. Jobling, M. A., Hurles, M. E. & Tyler-Smith, C. Human evolutionary genetics (Garland Science, New York, 2004).
101. Jones, S. In the blood (Harper Collins, London, 1996).
102. Eaton, S. B. et al. Women's reproductive cancers in evolutionary context. Q. Rev. Biol. 69, 353-367 (1994).
103. Henderson, B. E., Ross, R. K., Pike, M. C. & Casagrande, J. T. Endogenous hormones as a major factor in human cancer. Cancer Res. 42, 3232-3239 (1982).
104. Mezzetti, M. et al. Population attributable risk for breast cancer: diet, mutrition, and physical exercise. J. Natl Cancer Inst. 90, 389-394 (1998).
105. Coffey, D. S. Similarities of prostate and breast cancer: evolution, diet, and estrogens. Urol. 57, 31-38 (2001).
106. Sakr, W. A., Haas, G. P., Cassin, B. F., Pontes, J. E. & Crissman, J. D. The frequence of carcinoma and intraepithelial neoplasia of the prostate in young male patients. J. Urol. 150, 379-385 (1993).
107. Dunne, D. W. & Cooke, A. A worm's eye view of the immune system: consequences for evolution of human autoimmune disease. Nature Rev. Immunol. 5, 420-426 (2005).
108. Yazdanbakhsh, M., Kremsner, P. G. & van Ree, R. Allergy, parasites and the hygiene hypothesis. Science 296, 490-494 (2002).
109. Bach, J. F. Mechanisms of disease: the effect of infections on susceptibility to autoimmune and allergic diseases. N. Engl. J. Med. 347, 911-920 (2002).
110. Kolb, H. & Elliott, R. B. Increasing incidence of IDDM a consequence of improved hygiene? Diabetologia 37, 729-731 (1994).
111. Greaves, M. F. Aetiology of acute leukaemia. Lancet 349, 344-349 (1997).
112. Le Souéf, P. N., Goldblatt, J. & Lynch, N. R. Evolutionary adaptation of inflammatory immune responses in human beings. Lancet 356, 242-244 (2000).
113. Tsao, J.-L. et al. Genetic reconstruction of individual colorectal tumor histories. Proc. Natl Acad. Sci. USA 97, 1236-1241 (2000).
114. Gatenby, R. A. & Vincent, T. L. An evolutionary model of carcinogenesis. Cancer Res. 63, 6212-6220 (2003).
115. Michor, F., Iwasa, Y. & Nowak, M. A. Dynamics of cancer progression. Nature Rev. Cancer 4, 197-205 (2004).
116. Crespi, B. & Summers, K. Evolutionary biology of cancer. Trends Ecol. Evol. 20, 545-552 (2005).
117. Nagy, J. D. Competition and natural selection in a mathematical model of cancer. Bull. Math. Biol. 66, 663-668 (2004).
118. Bonnet, D. & Dick, J. E. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nature Med. 3, 730-737 (1997).
119. Singh, S. K., Clarke, I. D., Hide, T. & Dirks, P. B. Cancer stem cells in nervous sytem tumors. Oncogene 23, 7267-7273 (2004).
120. Bao, S. et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 444, 756-760 (2006).
121. O'Brien, C. A., Pollett, A., Gallinger, S. & Dick, J. E. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 445, 106-110 (2006).
122. Partridge, L. & Gems, D. Beyond the evolutionary theory of ageing, from functional genomics to evo-gero. Trends Ecol. Evol. 21, 334-340 (2006).
123. Kirkwood, T. B. L. Understanding the odd science of ageing. Cell 120, 437-447 (2005).
124. Medawar, P. B. An unsolved problem in biology (H K Lewis, London, 1952).
125. Lahdenpera, M., Lummaa, V., Helle, S., Tremblay, M. & Russell, A. F. Fitness benefits of prolonged post-reproductive lifespans in women. Nature 428, 178-181 (2004).
126. Williams, G. C. Pleiotropy, natural selection, and the evolution of senescence. Evolution 11, 398-411 (1957).
127. Balducci, L. & Ershler, W. B. Cancer and ageing: a nexus at several levels. Nature Rev. Cancer 5, 655-662 (2005).
128. Doll, R. An epidemiological perspective of the biology of cancer. Cancer Res. 38, 3573-3583 (1978).
129. DePinho, R. A. The age of cancer. Nature 408, 248-254 (2000).
130. Frank, S. A. Age-specific incidence of inherited versus sporadic cancers: a test of the multistage theory of carcinogenesis. Proc. Natl Acad. Sci. USA 102, 1071-1075 (2005).
131. Frank, S. A. Age-specific acceleration of cancer. Curr. Biol. 14, 242-246 (2004).
132. Peto, R., Roe, F. J. C., Lee, P. N., Levy, L. & Clack, J. Cancer and ageing in mice and men. Br. J. Cancer 32, 411-426 (1975).
133. Peto, J. Cancer epidemiology in the last century and the next decade. Nature 411, 390-395 (2001).
134. Rudolph, K. L. et al. Longevity, stress response, and cancer in aging telomerase-deficient mice. Cell 96, 701-712 (1999).
135. Campisi, J. Aging and cancer: the double-edged sword of replicative senescence. J. Am. Geriatr. Soc. 45, 482-488 (1997).
136. Dunn, G. P., Old, L. J. & Schreiber, R. D. The immunobiology of cancer immunosurveillance and immunoediting. Immunity 21, 137-148 (2004).
137. Foulds, L. The natural history of cancer. J. Chronic Dis. 8, 2-37 (1958).
138. Hanahan, D. & Weinberg, R. A. The hallmarks of cancer. Cell 100, 57-70 (2000).
139. Weinstein, B. S. & Ciszek, D. The reserve-capacity hypothesis: evolutionary origins and modern implications of the trade-off between tumor-suppression and tissue-repair. Exp. Gerontol. 37, 615-627 (2002).
140. Tyner, S. D. et al. p53 mutant mice that display early ageing-associated phenotypes. Nature 415, 45-53 (2002).
141. Campisi, J. Cancer and ageing: rival demons? Nature Rev. Cancer 3, 339-349 (2003).
142. Beausejour, C. M. & Campisi, J. Balancing regeneration and cancer. Nature 443, 404-405 (2006).
143. Greaves, M. Cancer causation: the Darwinian downside of past success? Lancet Oncol 3, 244-251 (2002).
144. Poole, A. J. et al. Prevention of Brca1-mediated mammary tumorigenesis in mice by a progesterone antagonist. Science 314, 1467-1470 (2006).
145. Jordan, V. C. Chemoprevention of breast cancer with selective oestrogen-receptor modulators. Nature Rev. Cancer 7, 46-53 (2007).
146. Roden, R. & Wu, T.-C. How will HPV vaccines affect cervical cancer? Nature Rev. Cancer 6, 753-763 (2006).
147. Artandi, S. E. et al. Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice. Nature 406, 641-645 (2000).
148. Greaves, M. Is telomerase activity in cancer due to selection of stem cells and differentiation arrest? Trends Genet. 12, 127-128 (1996).
149. Balkwill, F., Charles, K. A. & Mantovani, A. Smoldering and polarized inflammation in the initiation and promotion of malignant disease. Cancer Cell 7, 211-217 (2005).
150. Coussens, L. M. & Werb, Z. Inflammation and cancer. Nature 420, 860-867 (2002).
151. Carmeliet, P. Angiogenesis in health and disease. Nature Med. 9, 653-660 (2003).
152. Folkman, J. Role of antigenesis in tumor growth and metastasis. Semin. Oncol. 29, 15-18 (2002).